Composition
- Active ingredients
- LAMIVUDINE, NEVIRAPINE, AND STAVUDINE 150MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA022537.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Lamivudine, Nevirapine, and Stavudine
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Macleods Pharma
- Status
- Tentative approval
- FDA approval
- 30 Aug 2010
- Application
- NDA022537-001